原发性高血压患者血和尿中性粒细胞明胶酶相关脂质运载蛋白的改变及临床意义

doi:10.3969/j.issn.1006-7795.2013.04.025

首都医科大学学报 ›› 2013, Vol. 34 ›› Issue (4): 605-608.doi: 10.3969/j.issn.1006-7795.2013.04.025

原发性高血压患者血和尿中性粒细胞明胶酶相关脂质运载蛋白的改变及临床意义

侯菲¹, 缪洁萍¹, 蔡红梅¹, 牛栋², 李振文³, 马洁丹¹, 刘菁⁴

1. 首都医科大学电力教学医院肾内科, 北京 100073;
2. 武警北京总队第三医院医务处, 北京 100141;
3. 首都医科大学电力教学医院检验科, 北京 100073;
4. 首都医科大学电力教学医院神经内科, 北京 100073

收稿日期:2012-12-17 出版日期:2013-08-21 发布日期:2013-07-20
通讯作者: 侯菲 E-mail:741118623@qq.com
基金资助:
华北电网有限公司劳动卫生与职业病研究所基金(8AE000310003)。

Changes of neutrophil gelatinase-associated lipocalin in patients with primary hypertension and its clinical significance

HOU Fei¹, MIAO Jieping¹, CAI Hongmei¹, NIU Dong², LI Zhenwen³, MA Jiedan¹, LIU Jing⁴

1. Division of Nephrology, Beijing Electric Power Hospital, Teaching Hospital of Capital Medical University, Beijing 100073, China;
2. Infirmary, The Third Hospital of Beijing Group, China Armed Police Force, Beijing 100141, China;
3. Clinical Laboratory, Beijing Electric Power Hospital, Teaching Hospital of Capital Medical University, Beijing 100073, China;
4. Division of Neurology, Beijing Electric Power Hospital, Teaching Hospital of Capital Medical University, Beijing 100073, China

Received:2012-12-17 Online:2013-08-21 Published:2013-07-20
Supported by:
This study was supported by North China Grid Company Limited Labor hygiene and Occupation Disease Research Institute(8AE000310003).

摘要/Abstract

摘要：

目的检测原发性高血压患者血清和尿液中性粒细胞明胶酶相关脂质运载蛋白(neutrophil gelatinase-associated lipocalin,NGAL)浓度,探讨其临床意义。方法 117例原发性高血压患者和110例健康体检者作为研究对象,酶联免疫吸附方法检测血NGAL和尿NGAL浓度,同时测血肌酐及尿β2微球蛋白(β2-microglobulin,β2-mG),两组间进行比较。结果高血压组患者血NGAL浓度(1.88±1.49)μg/L、尿NGAL浓度(1.19±0.64)μg/L,对照组血NGAL浓度(0.78±1.01)μg/L、尿NGAL浓度(0.58±0.32)μg/L。高血压患者血NGAL、尿NGAL浓度均高于对照组(P<0.05)。两组间血肌酐比较差异无统计学意义(P>0.05)。高血压患者尿β2-mG较对照组升高,差异有统计学意义(P<0.05)。结论原发性高血压患者血清及尿NGAL浓度升高,这对于早期发现、早期防治高血压性肾损害有重要的临床意义。

Abstract:

Objective To investigate the changes of serum and urine neutrophil gelatinase-associated lipocalin(NGAL) in patients with primary hypertension and its clinical significance. Methods A total of 117 patients with primary hypertension and 110 healthy persons were studied. We detected serum and urine NGAL protein levels with enzyme linked immunosorbent assay(ELISA), serum creatinine(Scr) and urine β2-mG. Results The concentration of serum NGAL in hypertensive patients were(1.88±1.49)μg/L, urine NGAL were(1.19±0.64)μg/L, the serum NGAL of control group were(0.78±1.01)μg/L, urine NGAL were(0.58±0.32)μg/L. Serum and urine NGAL were significantly higher in patients with hypertension than the control group(P<0.05). The difference between hypertension group and control group in urine β2-mG was statistically significant(P<0.05), but not in Scr(P>0.05). Conclusion The serum and urine NGAL levels of patients with primary hypertension were significantly higher, detection of serum and urine level of NGAL in hypertension patients may have an important clinical significance in diagnosis, treatment and prognosis of hypertensive nephropathy.

Key words: neutrophil gelatinase-associated lipocalin, primary hypertension, hypertensive nephropathy

中图分类号:

侯菲, 缪洁萍, 蔡红梅, 牛栋, 李振文, 马洁丹, 刘菁. 原发性高血压患者血和尿中性粒细胞明胶酶相关脂质运载蛋白的改变及临床意义[J]. 首都医科大学学报, 2013, 34(4): 605-608.

HOU Fei, MIAO Jieping, CAI Hongmei, NIU Dong, LI Zhenwen, MA Jiedan, LIU Jing. Changes of neutrophil gelatinase-associated lipocalin in patients with primary hypertension and its clinical significance[J]. Journal of Capital Medical University, 2013, 34(4): 605-608.

参考文献

[1] 周福德,王梅.北京市血液透析的发展与质量改进[J].中国血液净化,2006,5(3):117-118.

[2] Yang H N, Boo C S, Kim M G, et al. Urine neutrophil gelatinase-associated lipocalin:an independent predictor of adverse outcomes in acute kidney injury[J]. Am J Nephrol, 2010,31(6):501-509.

[3] Ding H, He Y, Li K, et al. Urinary neutrophil gelatinase-associated lipocalin(NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy[J]. Clin Immunol, 2007,123(2):227-234.

[4] 华琦.高血压诊疗新进展[J].中国心血管病研究杂志,2006,4(2):85-88.

[5] Kjeldsen L, Johnsen A H, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase[J]. J Biol Chem, 1993,268(14):10425-10432.

[6] Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin(NGAL) as a marker of kidney damage[J]. Am J Kidney Dis, 2008,52(3):595-605.

[7] Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage[J]. Kidney Int, 2007,71(10):967-970.

[8] Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated Lipocalin(NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet, 2005,365(9466):1231-1238.

[9] Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated Lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity[J]. Am J Nephrol, 2004,24(3):307-315.

[10] Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin[J]. J Am Soc Nephrol, 2004,15(12):3073-3082.

[11] Mori K, Lee H T, Rapoport D, et al. Endocytic delivery of lopocalin-siderophore-iron complex rescues the kideny from ischemia-reperfusion injury[J]. J Clin Invest, 2005,115(3):610-621.

[12] Friedl A, Storsz S P, Buckley P, et al. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression[J]. Histochem J, 1999,31(7):433-441.

[13] 王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:1662-1668.

[14] 徐浩彦,刘立山,刘英学.高血压病早期肾损害相关指标研究[J].中国煤炭工业医学杂志,2011,14(2):185-186.

[15] 赵丹,张子新.动态血压与高血压左心室肥厚及肾功能的关系[J].中国医科大学学报,2011,40(8):741-743.

[16] 薛志强,童俊容.慢性肾脏疾病血清和尿液NGAL的改变及其临床意义[J].中国中西医结合肾病杂志,2010,11(5):440-441.

[17] Malyszko J, Malyszko J S, Bachorzewska-Gajewska H, et al. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients[J]. Transplant Proc, 2009,41(1):158-161.

原发性高血压患者血和尿中性粒细胞明胶酶相关脂质运载蛋白的改变及临床意义

Changes of neutrophil gelatinase-associated lipocalin in patients with primary hypertension and its clinical significance

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	周亚群, 丁存涛, 孙希鹏, 李静, 华琦. 原发性高血压患者红细胞分布宽度、中性粒细胞/淋巴细胞比值与内皮功能关系的研究[J]. 首都医科大学学报, 2018, 39(2): 292-298.
[2]	吕曼. 小剂量氢氯噻嗪联合厄贝沙坦治疗原发性高血压的临床观察[J]. 首都医科大学学报, 2018, 39(1): 148-152.
[3]	孙希鹏, 丁存涛, 周亚群, 朱玮玮, 谭静, 李静, 华琦. 松龄血脉康对轻度原发性高血压病人血压及糖脂代谢的影响[J]. 首都医科大学学报, 2017, 38(3): 381-385.
[4]	周亚群, 丁存涛, 孙希鹏, 李静, 朱玮玮, 华琦. 原发性高血压病人超敏C反应蛋白与血压及血管内皮功能关系的研究[J]. 首都医科大学学报, 2017, 38(3): 397-400.
[5]	丁存涛, 周亚群, 孙希鹏, 李静, 朱玮玮, 华琦. 糖脂代谢对原发性高血压病人血管内皮功能的影响[J]. 首都医科大学学报, 2017, 38(3): 401-405.
[6]	李敬, 华琦, 刘建峰, 罗鸿宇, 朱玮玮. 原发性高血压患者左心房内径与红细胞分布宽度的关系[J]. 首都医科大学学报, 2015, 36(3): 405-409.
[7]	侯海霞;华琦;陈慧敏;刘荣坤;杨峥. 原发性高血压患者血压变异性与肾功能损害的相关研究[J]. 首都医科大学学报, 2011, 32(5): 626-628.
[8]	谭静;华琦;闻静;邢绣荣;刘荣坤;杨峥. 原发性高血压病患者大动脉僵硬度与肌酐清除率的相关性[J]. 首都医科大学学报, 2011, 32(3): 388-391.
[9]	刘冲;杜忠东;李霞;段超. 住院儿童高血压的病因分析及鉴别诊断[J]. 首都医科大学学报, 2010, 31(2): 187-191.
[10]	唐玉平;李鹏高;邢晓然;余振球;孙丽颖;肖忠新;张淑华;吴惠慧;褚金花;李卫新;甄亚平. 膳食补充条斑紫菜对高血压患者血管内皮功能的影响[J]. 首都医科大学学报, 2008, 29(4): 475-478.
[11]	郭韶洁;赵秀丽;武峰;崔艳丽;王淑民;李嘉静;周辉;杨凌. 内皮型一氧化氮合酶基因G894T多态性与替米沙坦降压效果的相关性[J]. 首都医科大学学报, 2007, 28(1): 107-109.
[12]	李秀季;黄雯. 原发性高血压肾损害及肾实质性高血压患者MTHFR基因多态性分析[J]. 首都医科大学学报, 2006, 27(4): 497-500.
[13]	李东宝;华琦;皮林. 内皮型一氧化氮合酶基因G894T和G蛋白β3亚单位基因C825T多态性对高血压的协同作用[J]. 首都医科大学学报, 2006, 27(4): 480-484.
[14]	华琦;许骥;李东宝;陈海翎;郭金成;刘荣坤;杨峥. 醛固酮合成酶基因CYP11B₂(-344T/C)多态性对北京汉族高血压患者RAAS系统的影响[J]. 首都医科大学学报, 2006, 27(3): 361-364.
[15]	李东宝;华琦;皮林. 内皮型一氧化氮合酶基因T786C多态性与原发性高血压的相关关系[J]. 首都医科大学学报, 2006, 27(2): 226-229.